| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | Common Stock | Options Exercise | $73,140 | +391 | +5.5% | $187.06 | 7,473 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $21,699 | -116 | -1.6% | $187.06 | 7,357 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $81,558 | +436 | +5.9% | $187.06 | 7,793 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $20,202 | -108 | -1.4% | $187.06 | 7,685 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $67,529 | +361 | +4.7% | $187.06 | 8,046 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $16,461 | -88 | -1.1% | $187.06 | 7,958 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $50,132 | +268 | +3.4% | $187.06 | 8,226 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $12,346 | -66 | -0.8% | $187.06 | 8,160 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $144,410 | +772 | +9.5% | $187.06 | 8,932 | 01 Mar 2025 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $35,167 | -188 | -2.1% | $187.06 | 8,744 | 01 Mar 2025 | Direct | |
| holding | AVY | Common Stock (Savings Plan) | 575 | 01 Mar 2025 | Savings Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | 2025 MSU Award | Award | $0 | +1,745 | $0.000000 | 1,745 | 01 Mar 2025 | Common Stock | 1,745 | $0.000000 | Direct | F1 | |
| transaction | AVY | 2025 PU Award | Award | $0 | +1,816 | $0.000000 | 1,816 | 01 Mar 2025 | Common Stock | 1,816 | $0.000000 | Direct | F2 | |
| transaction | AVY | 2021 MSU Award | Options Exercise | $0 | -391 | -100% | $0.000000 | 0 | 01 Mar 2025 | Common Stock | 391 | $0.000000 | Direct | F3 |
| transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -436 | -49% | $0.000000 | 450 | 01 Mar 2025 | Common Stock | 436 | $0.000000 | Direct | F4 |
| transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -361 | -33% | $0.000000 | 729 | 01 Mar 2025 | Common Stock | 361 | $0.000000 | Direct | F5 |
| transaction | AVY | 2024 MSU Award | Options Exercise | $0 | -268 | -24% | $0.000000 | 851 | 01 Mar 2025 | Common Stock | 268 | $0.000000 | Direct | F6 |
| transaction | AVY | 2022 PU Award | Options Exercise | $0 | -772 | -100% | $0.000000 | 0 | 01 Mar 2025 | Common Stock | 772 | $0.000000 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period. |
| F2 | Performance units (PUs) vest, at the end of fiscal year 2027, provided certain performance objectives are met as determined by the Compensation Committee in February 2028. Each PU represents a contingent right to receive one share of common stock. |
| F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2021 at 128% of target based on our absolute total stockholder return in excess of 10% during the 2021-2024 performance period, plus dividend equivalents accrued during the period. |
| F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2022 at 92% of target based on our absolute total stockholder return during the 2022-2024 performance period, plus dividend equivalents accrued during the period. |
| F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2024 performance period, plus dividend equivalents accrued during the period. |
| F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2024 at 93% of target based on our absolute total stockholder return during the 2024 performance period, plus dividend equivalents accrued during the period. |
| F7 | Shares reflect the vesting of PUs granted in March 2022 at 50% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our capped relative total stockholder return of 100% of target. |